ReviewPublished 7 January 2026To treat or not to treat: a state-of-the-art overview of smoldering multiple myelomaAyushi Garg · Srinivas DevarakondaFrontiers in Hematologydoi 10.3389/frhem.2025.1706219
Original ResearchPublished 12 December 2025A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system dataBaiqing Huang · Yirou Ma · Wenli Wang · Shaorui Gu · Xisheng WangFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1721656
Mini ReviewPublished 8 December 2025Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disordersBiljana Horn · Giovanni Mambrini · Maureen Roden · Caralee Schaefer · Dirk Thye · Mauro MagnaniFrontiers in Drug Deliverydoi 10.3389/fddev.2025.1730142
Epigenetics and EpigenomicsPublished 30 October 2025Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restorationMuhammad Javid Iqbal · Luis A. SalazarFrontiers in Epigenetics and Epigenomicsdoi 10.3389/freae.2025.1691949
Science archivePublished 9 July 2025Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in JapanHidehisa Saeki · Makiko Usami · Katsuhisa Suzuki · Michika Mochizuki · Kazuhiko ArimaJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14794
